Both Keytruda and Jemperli already have approvals as monotherapies in second-line or later endometrial cancer settings, but approval in the first-line setting would unlock a larger eligible ...

Regeneron Pharmaceuticals' fourth quarter results beat my and Wall Street analysts' expectations. See why REGN stock is a top ...

and is a key approval for the drug as it fends off a challenge in endometrial cancer from MSD's rival PD-1 inhibitor Keytruda (pembrolizumab). Jemperli was the first drug in the class to be ...

GSK's revenue and EPS exceeded my expectations and those of analysts. Check out the reasons why I am upgrading GSK stock's ...

The combination of Padcev and Keytruda showed promising clinical activity in UTUC patients, with a 25% ORR in primary lesions and 35% in target lesions. The study included 22 patients with intact ...

In the first best-on-best matchup between Team USA and Canada in nine years, the United States pulled out a 3-1 win in the 4 Nations Face-Off Saturday night in Montreal. A fiery start led to a ...

So, you've decided you want a shiny new Galaxy flagship and that you won't settle for the smaller, more compact, vanilla model? Presumably, the Ultra is either superfluous or too expensive for you ...

Also in Europe, officials have endorsed GSK's Jemperli to treat all adult patients with primary advanced or recurrent endometrial cancer, including those with mismatch repair proficient (MMRp ...

So, you are in the market for a powerful compact flagship phone, and you are ready to dig deep in your pocket for one of the world's heavy-hitters, the Samsung Galaxy S25 and the Apple iPhone 16 Pro?

Image: Arsenal boss Mikel Arteta (left) will take his side to Ruben Amorim's Man Utd on Sunday March 9 Arsenal's matches against Manchester United and Chelsea are among the seven Premier League ...